Picornaviridae Infections

Virus diseases caused by the PICORNAVIRIDAE.
Also Known As:
Infections, Picornaviridae; Infections, Picornavirus; Infection, Picornaviridae; Infection, Picornavirus; Picornaviridae Infection; Picornavirus Infection; Picornavirus Infections
Networked: 47 relevant articles (1 outcomes, 2 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Infection
2. Inflammation
3. HIV Infections (HIV Infection)
4. Virus Diseases (Viral Diseases)
5. Shock


1. van Kuppeveld, Frank J M: 3 articles (10/2014 - 01/2010)
2. Semler, Bert L: 3 articles (11/2012 - 09/2007)
3. Langereis, Martijn A: 2 articles (10/2014 - 11/2012)
4. Feng, Qian: 2 articles (10/2014 - 11/2012)
5. Wileman, Thomas: 2 articles (11/2013 - 03/2005)
6. Virgen-Slane, Richard: 2 articles (11/2012 - 09/2012)
7. Vuorinen, Tytti: 2 articles (06/2007 - 05/2002)
8. Zhou, Zhigang: 1 article (11/2013)
9. Mogensen, Mette M: 1 article (11/2013)
10. Powell, Penny P: 1 article (11/2013)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Picornaviridae Infections:
1. AntibodiesIBA
2. Neutralizing AntibodiesIBA
3. pleconarilIBA
01/01/2012 - "Pleconaril is a novel antiviral drug being developed by Schering-Plough to treat Picornaviridae infections, and is in its late clinical trials stage. "
04/01/2002 - "This includes, for the treatment of HIV infections, virus adsorption inhibitors (cosalane derivatives, cyanovirin-N), co-receptor antagonists (TAK-779, AMD3100), viral fusion inhibitors (pentafuside T-20, betulinic acid derivatives), viral uncoating inhibitors (azodicarbonamide), nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs: emtricitabine, amdoxovir, dOTC, d4TMP prodrugs, tenofovir disoproxil fumarate), non-nucleoside reverse transcriptase inhibitors (NNRTIs: thiocarboxanilide UC-781, capravirine, SJ-3366, DPC 083, TMC 125/R165335), integrase inhibitors (diketo acids), transcription inhibitors (temacrazine, flavopiridol), protease inhibitors (atazanavir, mozenavir, tipranavir); for the treatment of RSV and paramyxovirus infections, viral fusion inhibitors (R170591, VP-14637, NMS03); for the treatment of picornavirus infections, viral uncoating inhibitors (pleconaril); for the treatment of pesti- (hepaci-, flavi-) virus infections, RNA replicase inhibitors (VP-32947); for the treatment of herpesvirus (HSV, VZV, CMV) infections, DNA polymerase inhibitors (A-5021, L- and D-cyclohexenylguanine); for the treatment of VZV infections, bicyclic furopyrimidine analogues; for the treatment of CMV infections, fomivirsen; for the treatment of DNA virus infections at large (papilloma-, polyoma-, herpes-, adeno- and poxvirus infections), cidofovir; for the treatment of influenza, neuraminidase inhibitors (zanamivir, oseltamivir, RWJ-270201); for the treatment of HBV infections, adefovir dipivoxil; for the treatment of HBV and HCV infections, N-glycosylation inhibitors (N-nonyl-deoxynojirimycin); and, finally, IMP dehydrogenase inhibitors and S-adenosylhomocysteine hydrolase inhibitors, for the treatment of various virus infections, including hemorrhagic fever virus infections."
4. RNA (Ribonucleic Acid)IBA
5. Proteins (Proteins, Gene)IBA
6. Viral RNAIBA
7. InterferonsIBA
8. CytokinesIBA
9. Messenger RNA (mRNA)IBA
10. Complement System Proteins (Complement)IBA

Therapies and Procedures

1. Drug Therapy (Chemotherapy)